Sood Ashwani, Seam Rajeev Kumar, Sethi Sandeep, Gupta Manish
Department of Radiotherapy and Oncology, Nuclear Medicine Center, Indira Gandhi Medical College, Shimla - 171 001, India.
Indian J Nucl Med. 2010 Apr;25(2):70-2. doi: 10.4103/0972-3919.72692.
Tc-99m methylene diphosphonate (MDP) bone scintigraphy has long been used for the evaluation of benign as well as malignant skeletal conditions. However, non-osseous tracer uptake on a bone scan is an unusual finding. There is a need to understand the pathophysiological basis of the non-osseous uptake, which may have a clinical relevance or deteriorating effect on the quality of the bone scan. We describe a case of multiple myeloma, where extraosseous uptake in the form of diffuse hepatic and splenic uptake, with almost normal skeletal tracer distribution, has been seen on the bone scan.
锝-99m亚甲基二膦酸盐(MDP)骨闪烁显像长期以来一直用于评估良性和恶性骨骼疾病。然而,骨扫描中出现非骨组织摄取示踪剂是一种不常见的发现。有必要了解这种非骨组织摄取的病理生理基础,其可能对骨扫描质量具有临床相关性或不良影响。我们描述了一例多发性骨髓瘤病例,在该病例的骨扫描中可见以肝脏和脾脏弥漫性摄取形式出现的骨外摄取,而骨骼示踪剂分布几乎正常。